Restricting activation-induced cytidine deaminase tumorigenic activity in B lymphocytes.
about
Regulation of Aicda expression and AID activityRepression of human activation induced cytidine deaminase by miR-93 and miR-155.The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia.Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing.Etiopathogenesis of Burkitt's lymphoma: a lesson from a BL-like in CD1 mouse immune to Plasmodium yoelii yoelii.Translocation capture sequencing: a method for high throughput mapping of chromosomal rearrangements.Dendritic cell-mediated activation-induced cytidine deaminase (AID)-dependent induction of genomic instability in human myeloma.Mouse model of endemic Burkitt translocations reveals the long-range boundaries of Ig-mediated oncogene deregulationInteractome maps of mouse gene regulatory domains reveal basic principles of transcriptional regulation.Epidemiology: clues to the pathogenesis of Burkitt lymphoma."Role of the B-cell receptor and the microenvironment in chronic lymphocytic leukemia''.Enhancer biology and enhanceropathies.Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols.Active RNAP pre-initiation sites are highly mutated by cytidine deaminases in yeast, with AID targeting small RNA genes.AID-induced T-lymphoma or B-leukemia/lymphoma in a mouse BMT model.
P2860
Q26853622-2EB7E7CD-7207-4BF7-BFD5-966979486AEAQ33989467-4923D523-BF29-4A38-9865-B87C7F625E05Q34099472-A1923C10-B3A0-47AB-BF25-149C46B0FD5BQ34473466-F4883F30-B255-481E-B5BE-C9ECE7F930CBQ35166501-2B885B9C-C97B-4F52-9968-C76EB5EB6E1DQ35773181-7ADAC501-512B-479F-9B9E-586442530D2BQ35849249-29B8AD14-AD3E-4709-BDF0-E3C89373339CQ36079387-7D71C736-7EB4-4EA7-A84B-50AC3DE418E4Q37527174-5FE64056-5C35-444A-8C8C-22EDF36D3ADDQ37977130-1D387D08-EF54-45A4-BF1D-942D8EFC9C4EQ38140625-1148BF4B-2E17-4335-8AD3-5DB4D6A6B2B6Q38193691-A428B6B7-A20E-42BD-9986-E416355D28B3Q40331337-D15D4665-CCB4-43E8-9669-29E35DEFFC31Q41733193-3537F69C-D469-49DD-A619-C92CA298A4A4Q43112724-7D5E1534-06D8-4FF5-A397-ED7986D29A7F
P2860
Restricting activation-induced cytidine deaminase tumorigenic activity in B lymphocytes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Restricting activation-induced cytidine deaminase tumorigenic activity in B lymphocytes.
@en
Restricting activation-induced cytidine deaminase tumorigenic activity in B lymphocytes.
@nl
type
label
Restricting activation-induced cytidine deaminase tumorigenic activity in B lymphocytes.
@en
Restricting activation-induced cytidine deaminase tumorigenic activity in B lymphocytes.
@nl
prefLabel
Restricting activation-induced cytidine deaminase tumorigenic activity in B lymphocytes.
@en
Restricting activation-induced cytidine deaminase tumorigenic activity in B lymphocytes.
@nl
P2093
P2860
P1433
P1476
Restricting activation-induced cytidine deaminase tumorigenic activity in B lymphocytes.
@en
P2093
Alexander L Kovalchuk
Arito Yamane
Michael Potter
Rafael Casellas
P2860
P304
P356
10.1111/J.1365-2567.2008.03050.X
P577
2009-03-01T00:00:00Z